| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b90d9b31a84fae4d2560a9313a7aa3bb |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K4-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0208 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6878
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B30-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate |
2017-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f89c182a35edcd179edcff2a6238f3f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9d81db1140431a31f487288cd5d2319
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021f05bb4af193a1ecd4772d49d98360
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_02427019d07ddc94588bf34dbbf3fae7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc4c6d4cd8444c76601f9a3865c8642c |
| publicationDate |
2019-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-110049774-A |
| titleOfInvention |
Small biota sequence variants of tumor-associated epitopes |
| abstract |
The present invention relates to cancer immunotherapy, in particular to sequence variants of tumor-associated epitope sequences. That is, the present invention provides a method for identifying small biota sequence variants of tumor-associated epitope sequences. Such small biota sequence variants can be used to prepare anticancer drugs because they are distinct from self-antigens and thus they can elicit strong immune responses. Accordingly, medicaments comprising sequence variants of small biota, methods of making these medicaments and uses of these medicaments are provided. |
| priorityDate |
2016-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |